Home Healthcare Medical Devices Active Wheelchair Market

Active Wheelchair Market Size, Share & Trends Analysis Report By Product Type (Manual Wheelchairs, Power Wheelchairs), By Indication (Alzheimer’s Disease, Amyotrophic lateral sclerosis (ALS), Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 04, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Active Wheelchair Market, By Product Type 2022-2034 (USD MILLION/ Units)
    1. Manual Wheelchairs
    2. Power Wheelchairs
  2. Active Wheelchair Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Alzheimer’s Disease
    2. Amyotrophic lateral sclerosis (ALS)
    3. Multiple Sclerosis
    4. Diabetes
    5. Cerebral Palsy
    6. Muscular Dystrophy
    7. Parkinson’s Disease
    8. Scoliosis
    9. Spina Bifida
    10. Spinal Cord Injury
    11. Others
  3. Regional Active Wheelchair Market
    1. North America
      1. North America Active Wheelchair Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Manual Wheelchairs
        2. Power Wheelchairs
      2. North America Active Wheelchair Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Alzheimer’s Disease
        2. Amyotrophic lateral sclerosis (ALS)
        3. Multiple Sclerosis
        4. Diabetes
        5. Cerebral Palsy
        6. Muscular Dystrophy
        7. Parkinson’s Disease
        8. Scoliosis
        9. Spina Bifida
        10. Spinal Cord Injury
        11. Others
      3. U.S.
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      4. Canada
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
    2. Europe
      1. Europe Active Wheelchair Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Manual Wheelchairs
        2. Power Wheelchairs
      2. Europe Active Wheelchair Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Alzheimer’s Disease
        2. Amyotrophic lateral sclerosis (ALS)
        3. Multiple Sclerosis
        4. Diabetes
        5. Cerebral Palsy
        6. Muscular Dystrophy
        7. Parkinson’s Disease
        8. Scoliosis
        9. Spina Bifida
        10. Spinal Cord Injury
        11. Others
      3. U.K.
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      4. Germany
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      5. France
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      6. Spain
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      7. Italy
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      8. Russia
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      9. Nordic
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      10. Benelux
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      11. Rest of Europe
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
    3. APAC
      1. APAC Active Wheelchair Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Manual Wheelchairs
        2. Power Wheelchairs
      2. APAC Active Wheelchair Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Alzheimer’s Disease
        2. Amyotrophic lateral sclerosis (ALS)
        3. Multiple Sclerosis
        4. Diabetes
        5. Cerebral Palsy
        6. Muscular Dystrophy
        7. Parkinson’s Disease
        8. Scoliosis
        9. Spina Bifida
        10. Spinal Cord Injury
        11. Others
      3. China
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      4. Korea
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      5. Japan
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      6. India
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      7. Australia
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      8. Taiwan
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      9. South East Asia
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      10. Rest of Asia-Pacific
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
    4. Middle East and Africa
      1. Middle East and Africa Active Wheelchair Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Manual Wheelchairs
        2. Power Wheelchairs
      2. Middle East and Africa Active Wheelchair Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Alzheimer’s Disease
        2. Amyotrophic lateral sclerosis (ALS)
        3. Multiple Sclerosis
        4. Diabetes
        5. Cerebral Palsy
        6. Muscular Dystrophy
        7. Parkinson’s Disease
        8. Scoliosis
        9. Spina Bifida
        10. Spinal Cord Injury
        11. Others
      3. UAE
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      4. Turkey
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      5. Saudi Arabia
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      6. South Africa
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      7. Egypt
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      8. Nigeria
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      9. Rest of MEA
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
    5. LATAM
      1. LATAM Active Wheelchair Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Manual Wheelchairs
        2. Power Wheelchairs
      2. LATAM Active Wheelchair Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Alzheimer’s Disease
        2. Amyotrophic lateral sclerosis (ALS)
        3. Multiple Sclerosis
        4. Diabetes
        5. Cerebral Palsy
        6. Muscular Dystrophy
        7. Parkinson’s Disease
        8. Scoliosis
        9. Spina Bifida
        10. Spinal Cord Injury
        11. Others
      3. Brazil
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      4. Mexico
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      5. Argentina
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      6. Chile
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      7. Colombia
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
      8. Rest of LATAM
        1. Manual Wheelchairs
        2. Power Wheelchairs
        3. Alzheimer’s Disease
        4. Amyotrophic lateral sclerosis (ALS)
        5. Multiple Sclerosis
        6. Diabetes
        7. Cerebral Palsy
        8. Muscular Dystrophy
        9. Parkinson’s Disease
        10. Scoliosis
        11. Spina Bifida
        12. Spinal Cord Injury
        13. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.